Evidence map›Paper›PMID 29754822›Full record

ArticleMolecular cell2018

A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation.

Thomas R Peskett, Frédérique Rau, Jonathan O'Driscoll, Rickie Patani, Alan R Lowe, Helen R Saibil

Open access · hybridAbstract read
In one paragraph

Article in Molecular cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 185 papers.

0numbers the graph read from it
0cells of the map it votes in
185citing papers in PubMed
17.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

185 citing papers in PubMed, 360 citations in OpenAlex.

  1. Chaperone-mediated remodelling of mutant huntingtin.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. amyloid-predict and LLPS-predict: Predicting phase separation propensities in the intrinsically disordered proteome.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. The Polymers of Life: Exploring Cellular Function Through Polymer Concepts.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  9. Review
  10. Article
  11. Chemical reviews · 2026
    Review
  12. Small heat shock proteins and biomolecular condensates.Cellular and molecular life sciences : CMLS · 2026
    Review
  13. Article
  14. Liquid-liquid phase separation in neural development.Cellular and molecular life sciences : CMLS · 2026
    Review
  15. Article
  16. Article
  17. GFP-free live neuron quantitative imaging reveals compartmentalization and growth dynamics of polyQ aggregates.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  18. Review
  19. Article
  20. Article

125 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Thomas R PeskettInstitute of Structural and Molecular Biology, Birkbeck College and University College London, London, WC1E 7HX, UK. Electronic address: thomas.peskett@bc.biol.ethz.ch.
Frédérique RauInstitute of Neurology, University College London, London, WC1N 3BG, UK.
Jonathan O'DriscollInstitute of Structural and Molecular Biology, Birkbeck College and University College London, London, WC1E 7HX, UK.
Rickie PataniInstitute of Neurology, University College London, London, WC1N 3BG, UK; The Francis Crick Institute, London, NW1 1AT, UK.
Alan R LoweInstitute of Structural and Molecular Biology, Birkbeck College and University College London, London, WC1E 7HX, UK; London Centre for Nanotechnology, University College London, London, WC1H 0AH, UK.
Helen R SaibilInstitute of Structural and Molecular Biology, Birkbeck College and University College London, London, WC1E 7HX, UK. Electronic address: h.saibil@mail.cryst.bbk.ac.uk.
University College London · GBBirkbeck, University of London · GBThe Francis Crick Institute · GB

Funding

Medical Research Council MR/K015826/1Medical Research Council MR/S006591/1Wellcome TrustWellcome Trust 079605/Z/06/ZWellcome Trust 101149/Z/13/AWellcome Trust 101488/Z/13/ZWellcome Trust 102401/Z/13/ZWellcome Trust 106249/Z/14/Z
6 · The paper itself

Abstract

Huntington's disease is caused by an abnormally long polyglutamine tract in the huntingtin protein. This leads to the generation and deposition of N-terminal exon1 fragments of the protein in intracellular aggregates. We combined electron tomography and quantitative fluorescence microscopy to analyze the structural and material properties of huntingtin exon1 assemblies in mammalian cells, in yeast, and in vitro. We found that huntingtin exon1 proteins can form reversible liquid-like assemblies, a process driven by huntingtin's polyQ tract and proline-rich region. In cells and in vitro, the liquid-like assemblies converted to solid-like assemblies with a fibrillar structure. Intracellular phase transitions of polyglutamine proteins could play a role in initiating irreversible pathological aggregation.

Indexed as

Phase TransitionExonsHEK293 CellsHumansHuntingtin ProteinHuntington DiseasePeptidesProtein Aggregation, PathologicalSaccharomyces cerevisiaeHuntingtin ProteinPeptidespolyglutamineaggregationelectron tomographyfluorescence microscopyhuntingtin exon1phase transitionpolyQ

Identifiers

PMID29754822
PMCPMC5971205
OpenAlexW2801412154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.